Feasibility and Utility of the Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.
*Wayne State University School of Medicine, Detroit, MI§US Medical Management, Grace Hospice Troy, MI†Hôpital de la Croix-Rousse, Hospices Civilis de Lyon‡Laboratoire de Toxicologie, ISPB Université de Lyon, Lyon, France∥Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania Philadelphia, PA.
Oscar A
OA
Linares
Michel
M
Tod
Annemarie L
AL
Daly
Raymond C
RC
Boston
D000701:Analgesics, Opioid / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006853:Hydrocodone / Q000493:pharmacokinetics* / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy / Q000235:genetics; D010597:Pharmacogenetics; D010641:Phenotype
D000701:Analgesics, Opioid; D006853:Hydrocodone